UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 28, 2013
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 000-10030
APPLE INC.
(Exact name of Registrant as specified in its charter)
California
94-2404110
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer Identification No.)
1 Infinite Loop
Cupertino, California
95014
(Address of principal executive offices)
(Zip Code)
Registrant s telephone number, including area code: (408) 996-1010
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes No
Indicate by check mark whether the registrant has submitted electronically
and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such files).
Yes No
Indicate by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
(Do not check if a smaller reporting company)
Smaller reporting company
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act).
Yes No
891,989,000 shares of common stock issued and outstanding as of January 10,
2014
Table of Contents
Apple Inc.
Form 10-Q
For the Fiscal Quarter Ended December 28, 2013
TABLE OF CONTENTS
Page
Part I
Item 1.
Financial Statements
Item 2.
Management s Discussion and Analysis of Financial Condition and Results of Operations
24
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
40
Item 4.
Controls and Procedures
40
Part II
Item 1.
Legal Proceedings
41
Item 1A.
Risk Factors
42
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
54
Item 3.
Defaults Upon Senior Securities
54
Item 5.
Other Information
54
Item 6.
Exhibits
55
Table of Contents
PART I. FINANCIAL INFORMATION
Item 1.
Financial Statements
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(In millions, except number of shares which are reflected in thousands and per share amounts)
Three Months Ended
December 28,
2013
December 29,
2012
Net sales
57,594
54,512
Cost of sales
35,748
33,452
Gross margin
21,846
21,060
Operating expenses:
Research and development
1,330
1,010
Selling, general and administrative
3,053
2,840
Total operating expenses
4,383
3,850
Operating income
17,463
17,210
Other income/(expense), net
246
462
Income before provision for income taxes
17,709
17,672
Provision for income taxes
4,637
4,594
Net income
13,072
13,078
Earnings per share:
Basic
14.59
13.93
Diluted
14.50
13.81
Shares used in computing earnings per share:
Basic
896,072
938,916
Diluted
901,452
947,217
Cash dividends declared per common share
3.05
2.65
See accompanying Notes to Condensed Consolidated Financial Statements.
Table of Contents
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
(In millions)
Three Months Ended
December 28,
2013
December 29,
2012
Net income
13,072
13,078
Other comprehensive income/(loss):
Change in foreign currency translation, net of tax
(67
(26
Change in unrecognized gains/losses on derivative instruments:
Change in fair value of derivatives, net of tax
213
146
Adjustment for net (gains)/losses realized and included in net income, net of tax
72
112
Total change in unrecognized gains/losses on derivative instruments, net of tax
285
258
Change in unrealized gains/losses on marketable securities:
Change in fair value of marketable securities, net of tax
(42
(66
Adjustment for net (gains)/losses realized and included in net income, net of tax
(11
(53
Total change in unrealized gains/losses on marketable securities, net of tax
(53
(119
Total other comprehensive income/(loss)
165
113
Total comprehensive income
13,237
13,191
See accompanying Notes to Condensed Consolidated Financial Statements.
Table of Contents
APPLE INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(In millions, except number of shares which are reflected in thousands)
December 28,
2013
September 28,
2013
ASSETS:
Current assets:
Cash and cash equivalents
14,077
14,259
Short-term marketable securities
26,634
26,287
Accounts receivable, less allowances of $94 and $99, respectively
14,200
13,102
Inventories
2,122
1,764
Deferred tax assets
3,742
3,453
Vendor non-trade receivables
10,998
7,539
Other current assets
8,574
6,882
Total current assets
80,347
73,286
Long-term marketable securities
118,131
106,215
Property, plant and equipment, net
15,488
16,597
Goodwill
2,022
1,577
Acquired intangible assets, net
4,105
4,179
Other assets
5,091
5,146
Total assets
225,184
207,000
LIABILITIES AND SHAREHOLDERS EQUITY:
Current liabilities:
Accounts payable
29,588
22,367
Accrued expenses
15,824
13,856
Deferred revenue
8,357
7,435
Total current liabilities
53,769
43,658
Deferred revenue non-current
3,071
2,625
Long-term debt
16,961
16,960
Other non-current liabilities
21,699
20,208
Total liabilities
95,500
83,451
Commitments and contingencies
Shareholders equity:
Common stock, no par value; 1,800,000 shares authorized; 892,447 and 899,213 shares issued and outstanding,
respectively
20,559
19,764
Retained earnings
109,431
104,256
Accumulated other comprehensive income/(loss)
(306
(471
Total shareholders equity
129,684
123,549
Total liabilities and shareholders equity
225,184
207,000
See accompanying Notes to Condensed Consolidated Financial Statements.
Table of Contents
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(In millions)
Three Months Ended
December 28,
2013
December 29,
2012
Cash and cash equivalents, beginning of the period
14,259
10,746
Operating activities:
Net income
13,072
13,078
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
2,144
1,588
Share-based compensation expense
681
545
Deferred income tax expense
1,253
1,179
Changes in operating assets and liabilities:
Accounts receivable, net
(1,098
(668
Inventories
(358
(664
Vendor non-trade receivables
(3,459
(2,174
Other current and non-current assets
(319
413
Accounts payable
8,191
6,145
Deferred revenue
1,368
1,611
Other current and non-current liabilities
1,195
2,373
Cash generated by operating activities
22,670
23,426
Investing activities:
Purchases of marketable securities
(48,397
(37,192
Proceeds from maturities of marketable securities
5,556
3,460
Proceeds from sales of marketable securities
30,302
23,002
Payments made in connection with business acquisitions, net
(525
(284
Payments for acquisition of property, plant and equipment
(1,985
(2,317
Payments for acquisition of intangible assets
(59
(138
Other
(52
Cash used in investing activities
(15,103
(13,521
Financing activities:
Proceeds from issuance of common stock
134
76
Excess tax benefits from equity awards
280
404
Taxes paid related to net share settlement of equity awards
(365
(534
Dividends and dividend equivalents paid
(2,769
(2,493
Repurchase of common stock
(5,029
(1,950
Cash used in financing activities
(7,749
(4,497
Increase/(decrease) in cash and cash equivalents
(182
5,408
Cash and cash equivalents, end of the period
14,077
16,154
Supplemental cash flow disclosure:
Cash paid for income taxes, net
3,387
1,890
Cash paid for interest
161
See accompanying Notes to Condensed Consolidated Financial Statements.
Table of Contents
Apple Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 Summary of Significant Accounting Policies
Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs,
manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players, and sells a variety of related software, services, peripherals, networking solutions, and third-party digital content and
applications. The Company sells its products worldwide through its retail stores, online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the
Company sells a variety of third-party iPhone, iPad, Mac, and iPod compatible products, including application software, and various accessories through its online and retail stores. The Company sells to consumers; small and mid-sized businesses; and
education, enterprise and government customers.
Basis of Presentation and Preparation
The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions
have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and assumptions that affect the
amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.
These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company s annual consolidated financial statements and the notes thereto for the fiscal
year ended September 28, 2013, included in its Annual Report on Form 10-K (the 2013 Form 10-K ). The Company s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. An additional week is
included in the first fiscal quarter approximately every six years to realign fiscal quarters with calendar quarters. The Company s fiscal years 2014 and 2013 each include 52 weeks. Unless otherwise stated, references to particular years,
quarters or months refer to the Company s fiscal years ended in September and the associated quarters or months of those fiscal years.
During the first quarter of 2014, the Company adopted updated accounting standards that (i) required disclosure of additional information about the amounts reclassified out of Accumulated Other
Comprehensive Income ( AOCI ) by component and (ii) required gross and net disclosures about offsetting assets and liabilities. The adoption of these updated standards only impacted the disclosures in the Notes to the Condensed
Consolidated Financial Statements; accordingly, the adoption had no impact on the Company s financial position or results of operations. The Company has provided these additional disclosures in this Form 10-Q in Note 8, Comprehensive
Income and Note 2, Financial Instruments, respectively.
Revenue Recognition
In 2013, the Company s combined best estimates of selling price ( ESPs ) for the unspecified software upgrade rights and
the rights to receive the non-software services included with its qualifying hardware devices ranged from $5 to $25. Beginning in the first quarter of 2014, the Company adjusted the combined ESPs for Mac from $20 to $40 to reflect additions to
unspecified software upgrade rights related to expansion of bundled essential software.
Table of Contents
Earnings Per Share
Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share
is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been
outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company s employee stock purchase plan and unvested restricted stock units
( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the
Company s common stock can result in a greater dilutive effect from potentially dilutive securities.
The following table
shows the computation of basic and diluted earnings per share for the three months ended December 28, 2013 and December 29, 2012 (in thousands, except net income in millions and per share amounts):
Three Months Ended
December 28,
2013
December 29,
2012
Numerator:
Net income
13,072
13,078
Denominator:
Weighted-average shares outstanding
896,072
938,916
Effect of dilutive securities
5,380
8,301
Weighted-average diluted shares
901,452
947,217
Basic earnings per share
14.59
13.93
Diluted earnings per share
14.50
13.81
Potentially dilutive securities representing 0.4 million and 3.7 million shares of common stock
for the three months ended December 28, 2013 and December 29, 2012, respectively, were excluded from the computation of diluted earnings per common share because their effect would have been antidilutive.
Note 2 Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company s cash and available-for-sale securities adjusted cost, gross unrealized
gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short- or long-term marketable securities as of December 28, 2013 and September 28, 2013 (in millions):
December 28, 2013
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
8,404
8,404
8,404
Level 1 (a):
Money market funds
2,236
2,236
2,236
Mutual funds
4,045
(248
3,797
3,797
Subtotal
6,281
(248
6,033
2,236
3,797
Level 2 (b):
U.S. Treasury securities
39,177
11
(62
39,126
629
8,498
29,999
U.S. agency securities
16,087
(37
16,057
1,016
3,854
11,187
Non-U.S. government securities
5,470
25
(141
5,354
276
5,078
Certificates of deposit and time deposits
1,438
1,438
668
494
276
Commercial paper
2,212
2,212
1,122
991
99
Corporate securities
57,709
297
(221
57,785
7,658
50,125
Municipal securities
6,246
49
(13
6,282
1,021
5,261
Mortgage- and asset-backed securities
16,221
23
(93
16,151
45
16,106
Subtotal
144,560
412
(567
144,405
3,437
22,837
118,131
Total
159,245
412
(815
158,842
14,077
26,634
118,131
Table of Contents
September 28, 2013
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
8,705
8,705
8,705
Level 1 (a):
Money market funds
1,793
1,793
1,793
Mutual funds
3,999
(197
3,802
3,802
Subtotal
5,792
(197
5,595
1,793
3,802
Level 2 (b):
U.S. Treasury securities
27,642
24
(47
27,619
431
7,554
19,634
U.S. agency securities
16,878
12
(52
16,838
177
3,412
13,249
Non-U.S. government securities
5,545
35
(137
5,443
50
313
5,080
Certificates of deposit and time deposits
2,344
2,344
1,264
844
236
Commercial paper
2,998
2,998
1,835
1,163
Corporate securities
54,586
275
(252
54,609
8,077
46,532
Municipal securities
6,257
45
(22
6,280
1,114
5,162
Mortgage- and asset-backed securities
16,396
23
(89
16,330
16,322
Subtotal
132,646
414
(599
132,461
3,761
22,485
106,215
Total
147,143
414
(796
146,761
14,259
26,287
106,215
(a)
The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.
(b)
The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and
liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
The Company may sell certain of its marketable securities prior to their stated maturities for strategic
reasons including, but not limited to, anticipation of credit deterioration and duration management. The net realized gains or losses recognized by the Company related to such sales were not significant during the three months ended
December 28, 2013 and December 29, 2012. The maturities of the Company s long-term marketable securities generally range from one to five years.
As of December 28, 2013 and September 28, 2013, gross unrealized losses related to individual securities that had been in a continuous loss position for 12 months or longer were not significant.
As of December 28, 2013, the Company considers the declines in market value of its marketable securities investment
portfolio to be temporary in nature and does not consider any of its investments other-than-temporarily impaired. The Company typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to
any one issuer. The policy requires investments generally to be investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio.
When evaluating an investment for other-than-temporary impairment the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto,
changes in market interest rates, and the Company s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment s cost basis. During the three months ended
December 28, 2013 and December 29, 2012, the Company did not recognize any significant impairment charges.
Table of Contents
Derivative Financial Instruments
The Company uses derivatives to partially offset its business exposure to foreign currency and interest rate risk. The Company may enter
into forward contracts, option contracts, swaps, or other derivative instruments to offset some of the risk on expected future cash flows, on net investments in certain foreign subsidiaries, and on certain existing assets and liabilities.
To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company s
subsidiaries whose functional currency is the U.S. dollar hedge a portion of forecasted foreign currency revenue. The Company s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion
of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to
12 months.
To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates,
the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates.
To help protect against adverse fluctuations in interest rates, the Company may enter into interest rate swaps, options, or other
instruments to offset a portion of the changes in income or expense due to fluctuations in interest rates.
The Company may
also enter into foreign currency forward and option contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. However, the
Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no
assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange rates.
The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company s accounting treatment for these instruments is based on whether the instruments are
designated as hedge or non-hedge instruments. The effective portions of cash flow hedges are recorded in AOCI until the hedged item is recognized in earnings. The effective portions of net investment hedges are recorded in other comprehensive income
( OCI ) as a part of the cumulative translation adjustment. The ineffective portions of cash flow hedges and net investment hedges are recorded in other income and expense. Derivatives that are not designated as hedging instruments are
adjusted to fair value through earnings in the financial statement line item to which the derivative relates.
Deferred gains
and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory
purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized as a component of other
income/(expense), net in the same period as the related income or expense is recognized. The Company s hedged foreign currency transactions and hedged interest rate transactions as of December 28, 2013 are expected to occur within 12
months and five years, respectively.
10
Table of Contents
Derivative instruments designated as cash flow hedges must be de-designated as hedges when
it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified
immediately into other income and expense. Any subsequent changes in fair value of such derivative instruments are reflected in other income and expense unless they are re-designated as hedges of other transactions. The Company did not recognize any
significant net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during the three months ended December 28, 2013 and December 29, 2012.
The Company s unrealized net gains and losses on net investment hedges, included in the cumulative translation adjustment account of
AOCI, were not significant as of December 28, 2013 and September 28, 2013. The ineffective portions and amounts excluded from the effectiveness test of net investment hedges are recorded in other income and expense.
The gain/loss recognized in other income and expense for foreign currency forward and option contracts not designated as hedging
instruments was not significant during the three months ended December 28, 2013 and December 29, 2012.
The
following table shows the notional principal amounts of the Company s outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of December 28, 2013 and September 28,
2013 (in millions):
December 28, 2013
September 28, 2013
Notional
Principal
Credit Risk
Amounts
Notional
Principal
Credit Risk
Amounts
Instruments designated as accounting hedges:
Foreign exchange contracts
23,553
331
35,013
159
Interest rate contracts
3,000
55
3,000
44
Instruments not designated as accounting hedges:
Foreign exchange contracts
16,859
48
16,131
25
The notional principal amounts for outstanding derivative instruments provide one measure of the
transaction volume outstanding and do not represent the amount of the Company s exposure to credit or market loss. The credit risk amounts represent the Company s gross exposure to potential accounting loss on derivative instruments that
are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency or interest rates at each respective date. The Company s gross
exposure on these transactions may be further mitigated by collateral received from certain counterparties. The Company s exposure to credit loss and market risk will vary over time as currency and interest rates change. Although the table
above reflects the notional principal and credit risk amounts of the Company s derivative instruments, it does not reflect the gains or losses associated with the exposures and transactions that the instruments are intended to hedge. The
amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.
11
Table of Contents
The Company generally enters into master netting arrangements, which are designed to reduce
credit risk by permitting net settlement of transactions with the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net
fair value of certain financial instruments fluctuates from contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values. As of December 28, 2013, the Company received
$165 million of cash collateral related to the derivative instruments under its collateral security arrangements, which were recorded as accrued expenses in the Condensed Consolidated Balance Sheet. As of September 28, 2013, the Company posted
cash collateral related to the derivative instruments under its collateral security arrangements of $164 million, which it recorded as other current assets in the Condensed Consolidated Balance Sheet. The Company did not have any derivative
instruments with credit-risk related contingent features that would require it to post additional collateral as of December 28, 2013 or September 28, 2013.
Under master netting arrangements with the respective counterparties to the Company s derivative contracts, the Company is allowed to net settle transactions with a single net amount payable by
one party to the other. However, the Company has elected to present the derivative assets and derivative liabilities on a gross basis in its Condensed Consolidated Balance Sheets. As of December 28, 2013 and September 28, 2013,
the potential effects of these rights of set-off associated with the Company s derivative contracts, including the effects of collateral, would be a reduction to both derivative assets and derivative liabilities of $356 million and
$333 million, respectively, resulting in net derivative liabilities of $66 million and $57 million, respectively.
The following tables show the Company s derivative instruments at gross fair value as reflected in the Condensed Consolidated